chr16-88429326-G-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001367624.2(ZNF469):c.1856G>T(p.Ser619Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,549,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S619N) has been classified as Uncertain significance.
Frequency
Consequence
NM_001367624.2 missense
Scores
Clinical Significance
Conservation
Publications
- brittle cornea syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
- brittle cornea syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- aortic disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ZNF469 | NM_001367624.2 | c.1856G>T | p.Ser619Ile | missense_variant | Exon 3 of 3 | ENST00000565624.3 | NP_001354553.1 | |
| ZNF469 | XM_047434810.1 | c.1856G>T | p.Ser619Ile | missense_variant | Exon 4 of 4 | XP_047290766.1 | ||
| LOC112268182 | XR_007065178.1 | n.250+638C>A | intron_variant | Intron 2 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZNF469 | ENST00000565624.3 | c.1856G>T | p.Ser619Ile | missense_variant | Exon 3 of 3 | 6 | NM_001367624.2 | ENSP00000456500.2 | ||
| ZNF469 | ENST00000437464.1 | c.1856G>T | p.Ser619Ile | missense_variant | Exon 1 of 2 | 5 | ENSP00000402343.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.00000672 AC: 1AN: 148824 AF XY: 0.0000125 show subpopulations
GnomAD4 exome AF: 0.0000236 AC: 33AN: 1397676Hom.: 0 Cov.: 62 AF XY: 0.0000305 AC XY: 21AN XY: 689344 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74314 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Cardiovascular phenotype Uncertain:1
The p.S619I variant (also known as c.1856G>T), located in coding exon 1 of the ZNF469 gene, results from a G to T substitution at nucleotide position 1856. The serine at codon 619 is replaced by isoleucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Brittle cornea syndrome 1 Uncertain:1
- -
ZNF469-related disorder Uncertain:1
The ZNF469 c.1856G>T variant is predicted to result in the amino acid substitution p.Ser619Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0028% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at